The Beauty Health Company / Fundamentals
Income statement
- Net revenue
€265.44M - Cost of goods sold
€102.20M - Gross profit
€163.25M - SG&A expenses
€196.48M - R&D expenses
€3.92M - EBITDA
€7.90M - D&A
€14.52M - EBIT
-€37.15M - Interest expenses
€9.91M - EBT
-€15.88M - Tax expenses
€392.95K - Net income
-€16.27M
Cash flow statement
- Net deferred tax
-€672.89K - Non-cash items
€13.62M - Changes in working capital
€3.72M - Operating cash flow
€33.75M - Capex
€2.53M - Other investing cash flow
-€8.06M - Net investing cash flow
-€4.84M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€351.81M - Other financing cash flow
€202.35M - Net financing cash flow
-€149.46M - Foreign exchange effects
€2.79M - Net change in cash
-€117.75M - Cash at end of period
€181.49M - Free cash flow
€36.28M
Balance sheet
- Cash and cash equivalents
€181.49M - Cash and short-term investments
€181.49M - Total receivables
€21.44M - Inventory
€50.67M - Other current assets
€8.45M - Total current assets
€262.06M - Property, plant & equipment
€13.05M - Goodwill
€108.10M - Intangible assets
€37.23M - Long-term investments
€0.00 - Other non-current assets
€11.39M - Total non-current assets
€172.47M - Total assets
€434.52M - Accounts payable
€19.67M - Short-term debt
€4.42M - Other current liabilities
€24.36M - Total current liabilities
€50.89M - Long-term debt
€318.09M - Deferred tax liabilities
€185.77K - Other non-current liabilities
€2.00M - Total non-current liabilities
€320.28M - Total liabilities
€371.17M - Common stock
€11.13K - Retained earnings
-€426.63M - Other equity
-€1.88M - Total equity
€63.35M - Total liabilities and shareholders' equity
€434.52M
Company information
- Market capitalization
€209.59M - Employees
769 - Enterprise Value
€395.02M
Company ratios
- Gross margin
-
61.5% Even with peer group: 62.1% - EBITDA margin
-
3.0% Even with peer group: 4.0% - EBIT margin
-
-14.0% Worse than peer group: 3.4% - EBT margin
-
-6.0% Worse than peer group: 0.0% - Net margin
-
-6.1% Better than peer group: -15.0% - ROE
-
-25.7% Much worse than peer group: -3.0% - ROA
-
-3.7% Worse than peer group: 10.1% - Asset turnover
-
61.1% Much worse than peer group: 1,427.1% - FCF margin
-
11.8% Worse than peer group: 21.9% - FCF yield
14.9% - Efficiency ratio
97.0% - Net sales per employee
-
€345.18K - Net income per employee
-
-€21.16K